Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 63201-63250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT03206099
NIAID Centralized Sequencing Protocol
N/ARecruiting
20,000 participants
Started: Jul 31, 2017 · Completed: Dec 31, 2029
4 conditions2 sponsors2 locations
NCT03104491
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
PHASE1/PHASE2Recruiting
44 participants
Started: Jul 31, 2017 · Completed: May 31, 2027
1 condition1 sponsor7 locations
NCT06331377
Clinical and Molecular Characteristics of Histiocytic Disorders
N/ARecruiting
500 participants
Started: Jul 27, 2017 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT03449264
Development of Clinical and Biological Database
NARecruiting
4,000 participants
Started: Jul 27, 2017 · Completed: Nov 30, 2037
4 conditions1 sponsor1 location
NCT03190928
Clonal Evolution in Follicular Lymphoma
N/ARecruiting
200 participants
Started: Jul 27, 2017 · Completed: Jan 1, 2029
1 condition1 sponsor1 location
NCT03024008
Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II
PHASE1/PHASE2Recruiting
20 participants
Started: Jul 27, 2017 · Completed: Jun 30, 2027
1 condition1 sponsor6 locations
NCT03201861
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
PHASE3Recruiting
762 participants
Started: Jul 27, 2017 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT03385109
The TransEnterix European Patient Registry
N/ARecruiting
500 participants
Started: Jul 25, 2017 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT03127761
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
N/ARecruiting
544 participants
Started: Jul 25, 2017 · Completed: Apr 30, 2028
1 condition2 sponsors1 location
NCT03400345
Human Upper Extremity Allotransplantation: F/U Protocol
N/ARecruiting
60 participants
Started: Jul 25, 2017 · Completed: Jul 30, 2036
3 conditions1 sponsor1 location
NCT03222635
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
NARecruiting
225 participants
Started: Jul 25, 2017 · Completed: Jul 25, 2028
3 conditions1 sponsor20 locations
NCT03251118
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
N/ARecruiting
15,000 participants
Started: Jul 24, 2017 · Completed: Oct 31, 2025
4 conditions1 sponsor37 locations
NCT04806295
The Leukemia and Lymphoma Society (LLS) National Research Registry
N/ARecruiting
1,000 participants
Started: Jul 24, 2017 · Completed: Jul 23, 2027
1 condition1 sponsor1 location
NCT03184545
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
PHASE3Recruiting
92 participants
Started: Jul 24, 2017 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT02999022
Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)
PHASE2Recruiting
160 participants
Started: Jul 21, 2017 · Completed: Jun 30, 2025
1 condition2 sponsors5 locations
NCT03151629
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
N/ARecruiting
5,000 participants
Started: Jul 21, 2017 · Completed: Jan 31, 2032
1 condition1 sponsor121 locations
NCT03233399
Modulating Movement Intention Via Cortical Stimulation
NARecruiting
30 participants
Started: Jul 20, 2017 · Completed: May 31, 2027
3 conditions1 sponsor1 location
NCT03245411
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
NARecruiting
110 participants
Started: Jul 20, 2017 · Completed: Dec 20, 2025
1 condition2 sponsors1 location
NCT03233646
Retinal Imaging in Neurodegenerative Disease
N/ARecruiting
2,000 participants
Started: Jul 20, 2017 · Completed: Dec 31, 2025
15 conditions4 sponsors1 location
NCT02541955
Use of Acthar in Rheumatoid Arthritis (RA) Related Flares
PHASE4Recruiting
40 participants
Started: Jul 20, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03223922
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
NARecruiting
24 participants
Started: Jul 19, 2017 · Completed: Dec 31, 2030
1 condition1 sponsor2 locations
NCT03152318
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PHASE1Recruiting
62 participants
Started: Jul 18, 2017 · Completed: Jan 31, 2027
14 conditions3 sponsors5 locations
NCT03296202
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
N/ARecruiting
7,200 participants
Started: Jul 18, 2017 · Completed: Jul 31, 2025
2 conditions4 sponsors24 locations
NCT03199651
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients with Stage IV Non-Small Cell Lung Cancer
NARecruiting
3,584 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2028
5 conditions1 sponsor1 location
NCT03251027
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
NARecruiting
125 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04529252
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
N/ARecruiting
1,000 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04221737
Early Use of Airway Pressure Release Ventilation (APRV) in ARDS
NARecruiting
150 participants
Started: Jul 15, 2017 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT03543215
Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?
N/ARecruiting
500 participants
Started: Jul 13, 2017 · Completed: Dec 10, 2025
2 conditions1 sponsor1 location
NCT03400371
Biology of Juvenile Myoclonic Epilepsy
N/ARecruiting
1,000 participants
Started: Jul 13, 2017 · Completed: Dec 31, 2026
1 condition8 sponsors15 locations
NCT03268668
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
N/ARecruiting
1,200 participants
Started: Jul 13, 2017 · Completed: Oct 31, 2027
5 conditions1 sponsor9 locations
NCT03916809
EMST in Patients Undergoing CRT for HNCA
NARecruiting
30 participants
Started: Jul 12, 2017 · Completed: Aug 1, 2025
2 conditions3 sponsors2 locations
NCT03191656
REDUCE LAP-HF III Corvia Protocol 1701
N/ARecruiting
500 participants
Started: Jul 12, 2017 · Completed: Jul 31, 2028
1 condition1 sponsor27 locations
NCT03219359
Autologous Stem Cell Transplant for Crohn's Disease
PHASE2Recruiting
50 participants
Started: Jul 12, 2017 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05954403
National Cohort on Congenital Defects of the Eye
N/ARecruiting
800 participants
Started: Jul 11, 2017 · Completed: Jul 31, 2037
5 conditions1 sponsor1 location
NCT05927454
Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
N/ARecruiting
500 participants
Started: Jul 11, 2017 · Completed: Jul 31, 2027
3 conditions1 sponsor1 location
NCT03215719
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma
PHASE2Recruiting
144 participants
Started: Jul 10, 2017 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT03253536
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
N/ARecruiting
100 participants
Started: Jul 10, 2017 · Completed: Jul 10, 2027
4 conditions1 sponsor1 location
NCT03984968
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
PHASE1/PHASE2Recruiting
34 participants
Started: Jul 10, 2017 · Completed: Jan 24, 2040
1 condition1 sponsor1 location
NCT03521648
Database for the Assessment of Efficacy and Safety of BPH Treatment
N/ARecruiting
500 participants
Started: Jul 7, 2017 · Completed: Dec 1, 2027
2 conditions1 sponsor1 location
NCT03976999
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
NARecruiting
300 participants
Started: Jul 5, 2017 · Completed: Jul 31, 2032
3 conditions1 sponsor1 location
NCT03214354
Nonmyeloablative Stem Cell Transplant in Children with Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
PHASE2Recruiting
12 participants
Started: Jul 5, 2017 · Completed: Jul 31, 2028
4 conditions1 sponsor1 location
NCT03787771
The Fecal Microbiota Transplantation Registry
N/ARecruiting
3,000 participants
Started: Jul 2, 2017 · Completed: Nov 30, 2046
1 condition1 sponsor1 location
NCT03198052
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
PHASE1Recruiting
30 participants
Started: Jul 1, 2017 · Completed: Aug 1, 2036
4 conditions3 sponsors2 locations
NCT07168330
Clinical and Radiological Evaluation of Total Ankle Replacement (ProtesiTT)
N/ARecruiting
100 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03422224
ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation
N/ARecruiting
50 participants
Started: Jul 1, 2017 · Completed: Jul 31, 2024
4 conditions1 sponsor1 location
NCT03142659
Evaluation and Management of Heart Failure Patients
N/ARecruiting
5,000 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT02675959
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
PHASE2Recruiting
40 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2027
1 condition8 sponsors4 locations
NCT06069505
Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study
N/ARecruiting
300 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT05990244
Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion
NARecruiting
100 participants
Started: Jul 1, 2017 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT03275493
CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia
PHASE1/PHASE2Recruiting
40 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location